Skip to main content
Livermore
Livermore
ZHEN

Parallel Advisors, LLC

SEC CIK
0001690010
Latest filing
Aug 5, 2026

HALO holding history

Halozyme Therapeutics, Inc. in every 13F filed by Parallel Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HALO overviewAll 13F holders of HALOFull Q2 2026 holdings

Shares (Q2 2026)
2,460
Value
$192.5K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of HALO by Parallel Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,460$192.5K<0.1%+432+21.3%AddedHolders
Q1 20262,028$131.1K<0.1%+147+7.8%AddedHolders
Q4 20251,881$126.6K<0.1%−6−0.3%ReducedHolders
Q3 20251,887$138.4K<0.1%−47−2.4%ReducedHolders
Q2 20251,934$100.6K<0.1%+59+3.1%AddedHolders
Q1 20251,875$119.6K<0.1%+208+12.5%AddedHolders
Q4 20241,667$79.7K<0.1%−15−0.9%ReducedHolders
Q3 20241,682$96.3K<0.1%−73−4.2%ReducedHolders
Q2 20241,755$91.9K<0.1%+110+6.7%AddedHolders
Q1 20241,645$66.9K<0.1%+1,279+349.5%AddedHolders
Q4 2023366$13.5K<0.1%−74−16.8%ReducedHolders
Q3 2023440$16.8K<0.1%+168+61.8%AddedHolders
Q2 2023272$9.81K<0.1%+140+106.1%AddedHolders
Q1 2023132$5.04K<0.1%−23−14.8%ReducedHolders
Q4 2022155$8.82K<0.1%−123−44.2%ReducedHolders
Q3 2022278$11.0K<0.1%+83+42.6%AddedHolders
Q2 2022195$9.00K<0.1%+39+25.0%AddedHolders
Q1 2022156$6.00K<0.1%+17+12.2%AddedHolders
Q4 2021139$6.00K<0.1%−208−59.9%ReducedHolders
Q3 2021347$14.0K<0.1%+254+273.1%AddedHolders
Q2 202193$4.00K<0.1%−59−38.8%ReducedHolders
Q1 2021152$6.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.